The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers
- 1 March 2003
- Vol. 44, S67-S77
- https://doi.org/10.1016/s0378-5122(02)00350-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogen Promotes Early Osteoblast Differentiation and Inhibits Adipocyte Differentiation in Mouse Bone Marrow Stromal Cell Lines that Express Estrogen Receptor (ER) orEndocrinology, 2002
- Estrogens and lipidsPostgraduate Medicine, 2002
- Estrogen Receptors and Are Differentially Expressed in Developing Human BoneJournal of Clinical Endocrinology & Metabolism, 2001
- Localization of Estrogen Receptor β Protein Expression in Adult Human BoneJournal of Bone and Mineral Research, 2001
- Carcinoma of the EndometriumDrugs, 2001
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous systemJournal of Comparative Neurology, 1997
- The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 1995
- Postmenopausal hot flushes: A disorder of thermoregulationMaturitas, 1980